KMT2A and acute lymphoblastic leukemia: Patients with B-ALL were further classified by their genetic markers and frequency: ETV6-RUNX1 (17.9%), hyperdiploidy (24.1%), TCF3-PBX1 (6.1%), KMT2A (7.0%) and BCR-ABL1 (6.6%).